M Yoshinouchi
Overview
Explore the profile of M Yoshinouchi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
395
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yamato K, Yamada T, Kizaki M, Ui-Tei K, Natori Y, Fujino M, et al.
Cancer Gene Ther
. 2007 Dec;
15(3):140-53.
PMID: 18157144
Persistent infection by high-risk types of human papillomaviruses (HPV) is a necessary cause of cervical cancer, with HPV16 the most prevalent, accounting for more than 50% of reported cases. The...
2.
Yamato K, Fen J, Kobuchi H, Nasu Y, Yamada T, Nishihara T, et al.
Cancer Gene Ther
. 2005 Sep;
13(3):234-41.
PMID: 16138119
Human cervical cancer is caused by high-risk types of human papillomavirus (HPV) such as HPV16 and HPV18, which possess the E6 and E7 oncogenes, whose concurrent expression is a prerequisite...
3.
Shinyo Y, Kodama J, Hongo A, Yoshinouchi M, Hiramatsu Y
Ann Oncol
. 2003 Sep;
14(10):1505-10.
PMID: 14504050
Background: Endoglycosidic heparanase degrades heparan sulfate glycosaminoglycans, and may be important in cancer invasion and metastasis, although its expression in human cervical cancer has not been characterized. Materials And Methods:...
4.
Kodama J, Hashimoto I, Seki N, Hongo A, Yoshinouchi M, Okuda H, et al.
Anticancer Res
. 2001 Nov;
21(4B):2983-7.
PMID: 11712798
Background: The role of thrombospondin (TSP) in tumor progression remains controversial. The association of TSP with clinicopathological features regarding prognostic significance was examined in patients with epithelial ovarian tumor. Materials...
5.
Kodama J, Hashimoto I, Seki N, Hongo A, Yoshinouchi M, Okuda H, et al.
Clin Cancer Res
. 2001 Sep;
7(9):2826-31.
PMID: 11555600
Purpose: TSP association with clinicopathological features, including microvessel count, regarding prognostic significance was examined in patients presenting with invasive cervical cancer. Experimental Design: Gene expression of TSP-1 and TSP-2 was...
6.
Seki N, Kodama J, Hashimoto I, Hongo A, Yoshinouchi M, Kudo T
Int J Oncol
. 2001 Jul;
19(2):305-10.
PMID: 11445843
The role of thrombospondin (TSP) in tumor angiogenesis and progression remains controversial. The expression of TSP-1 and TSP-2 mRNAs was assessed. Furthermore, TSP association with clinicopathological features, including microvessel count,...
7.
Hashimoto I, Kodama J, Seki N, Hongo A, Yoshinouchi M, Okuda H, et al.
Br J Cancer
. 2001 Jul;
85(1):93-7.
PMID: 11437408
Vascular endothelial growth factor-C (VEGF-C) has been implicated in lymphangiogenesis, the process of new lymphatics formation. The present study investigated VEGF-C mRNA expression in invasive cervical cancer tissue. Additionally, the...
8.
Kawanishi K, Yamamoto J, Miyagi Y, Nakamura K, Kodama J, Hongo A, et al.
Cancer Chemother Pharmacol
. 2001 May;
47(4):303-8.
PMID: 11345646
Purpose: The pharmacodynamic effects of cis-diammine(glycolato)platinum (nedaplatin, 254-S) in vitro have been reported, but the dosage and exposure time in vitro have not always been based on clinical observations of...
9.
Kawanishi K, Miyagi Y, Yamada S, Yamamoto J, Kodama J, Hongo A, et al.
Cancer Chemother Pharmacol
. 2001 Apr;
47(3):229-35.
PMID: 11320666
Purpose: Cell cycle non-specific anticancer agents such as cis-diamminedichloroplatinum(II) are believed to depend linearly on the value of the area under the drug concentration time curve, which is supported by...
10.
Kodama J, Hashimoto I, Seki N, Hongo A, Mizutani Y, Miyagi Y, et al.
Gan To Kagaku Ryoho
. 2001 Mar;
28(3):351-5.
PMID: 11265403
Recently, attempts have made to use radiotherapy in combination with chemotherapy in various solid tumors including cervical cancer. Twenty-four patients with locally advanced cervical cancer were treated with concurrent Carboplatin...